Diabetic Macular Oedema

Faricimab inhibits both angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways which may extend treatment durability beyond current anti-VEGF therapies for diabetic macular edema (DME). It was a pleasure to speak with Dr Jennifer Lim (University of Illinois Chicago, IL, USA) around the treat-and-extend regimen with faricimab in the YOSEMITE/RHINE (NCT03622580/NCT03622593) trials and the […]

Diabetic macular edema is characterised by exudative fluid accumulation in the macula and is the most common form of sight-threatening retinopathy in people with diabetes affecting one in 15 people with diabetes. Intraocular pharmacotherapy with anti-VEGF agents is the standard of care. It was a pleasure to speak with Dr Jennifer Lim (University of Illinois […]

The YOSEMITE/RHINE (NCT03622580/NCT03622593) trials were double-masked, active comparator–controlled, phase 3 trials investigating the efficacy, safety, and durability of faricimab 6.0 mg versus aflibercept 2.0 mg in patients with diabetic macular edema (DME). It was a pleasure to speak with Dr Andreas Pollreisz (Medical University of Vienna, Austria) around the YOSEMITE/RHINE trials as well as their […]

Diabetic macular edema is characterised by exudative fluid accumulation in the macula and is the most common form of sight-threatening retinopathy in people with diabetes affecting one in 15 people with diabetes. Intraocular pharmacotherapy with anti-VEGF agents is the standard of care. It was a pleasure to speak with Dr Andreas Pollreisz (Medical University of […]

It was great to catch up with Prof. Jakob Grauslund (Odense University Hospital, Odense, Denmark) to discuss the advantages of navigated laser photocoagulation systems and their advantages over traditional retinal laser for the treatment of diabetic macular oedema and proliferative diabetic retinopathy. The abstract ‘Navigated laser in DME and PDR?’ was presented at EURETINA 2022, […]

It was a pleasure to speak with Lloyd Clark (Palmetto Retina Center, West Columbia, SC, USA) about injection protocols demonstrating improvements in the long-term management of diabetic retinopathy and diabetic macular oedema, and his views on current treatment trends. Questions What injection protocols have demonstrated improvements in the long-term management of diabetic retinopathy and diabetic […]

It was a pleasure to catch up with Felix Datlinger (Medical University of Vienna, Vienna, Austria) about his study on functional and morphological long-term outcomes of indocyanine green angiography-guided laser therapy of teleangiectatic capillaries. Questions What was previously known about the functional and morphological long-term outcomes of indocyanine green angiography-guided laser therapy of teleangiectatic capillaries? […]